The efficacy and safety of Grafix® for the treatment of chronic diabetic foot ulcers: results of a multi‐centre, controlled, randomised, blinded, clinical trial

International Wound Journal - Tập 11 Số 5 - Trang 554-560 - 2014
Lawrence A. Lavery1, James Fulmer2, Karry Ann Shebetka3, Matthew Regulski4, Dean Vayser5, David L. Fried6, Howard Kashefsky7, Tammy M. Owings8, Janaki Nadarajah9
1Department of Plastic Surgery, University of Texas Southwestern, Dallas, TX, USA.
2River City Clinical Research, Jacksonville, FL, USA
3Clinical Trials of Texas San Antonio TX USA
4Ocean County Foot and Ankle, Toms River, NJ, USA
5ILD Research Center, Carlsbad, CA, USA
6Omega Medical Research Warwick RI USA
7University of North Carolina at Chapel Hill, Chapel Hill, NC USA
8Cleveland Clinic, Cleveland, OH, USA
9Aiyan Diabetes Center, Evans, GA, USA

Tóm tắt

AbstractIn a randomised, controlled study, we compared the efficacy of Grafix®, a human viable wound matrix (hVWM) (N = 50), to standard wound care (n = 47) to heal diabetic foot ulcers (DFUs). The primary endpoint was the proportion of patients with complete wound closure by 12 weeks. Secondary endpoints included the time to wound closure, adverse events and wound closure in the crossover phase. The proportion of patients who achieved complete wound closure was significantly higher in patients who received Grafix (62%) compared with controls (21%, P = 0·0001). The median time to healing was 42 days in Grafix patients compared with 69·5 days in controls (P = 0·019). There were fewer Grafix patients with adverse events (44% versus 66%, P = 0·031) and fewer Grafix patients with wound‐related infections (18% versus 36·2%, P = 0·044). Among the study subjects that healed, ulcers remained closed in 82·1% of patients (23 of 28 patients) in the Grafix group versus 70% (7 of 10 patients) in the control group (P = 0·419). Treatment with Grafix significantly improved DFU healing compared with standard wound therapy. Importantly, Grafix also reduced DFU‐related complications. The results of this well‐controlled study showed that Grafix is a safe and more effective therapy for treating DFUs than standard wound therapy.

Từ khóa


Tài liệu tham khảo

10.1016/j.diabres.2011.10.040

Centers for Disease Control and Prevention (CDC), 2008, 2007 National Diabetes Fact Sheet

10.2337/dc12-2625

10.1001/jama.293.2.217

10.1046/j.1524-4725.2001.00280.x

10.2337/dc12-0200

10.1111/j.1524-475X.2005.00083.x

10.2337/diacare.22.5.692

10.2337/diacare.26.6.1701

10.2337/diacare.24.2.290

10.1097/PRS.0b013e3181c722bb

10.5966/sctm.2011-0018

10.2307/2531692

10.1111/j.1742-481X.2009.00585.x

Regulski M, 2013, A retrospective analysis of a human cellular repair matrix for the treatment of chronic wounds, Ostomy Wound Manage, 59, 38

Armstrong DG, 1998, Peak foot pressures influence the healing time of diabetic foot ulcers treated with total contact casts, J Rehabil Res Dev, 35, 1

10.1097/PRS.0b013e3182024864

10.2337/diacare.19.8.818

10.2337/diacare.28.3.551

10.2337/diacare.28.3.555

10.2337/diacare.24.6.1019

10.2337/dc08-0771

10.1002/dmrr.2386

10.2337/diacare.12.6.384

Steed DL, 1996, Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group, J Am Coll Surg, 183, 61

10.1046/j.1524-475X.2002.10603.x

10.1016/j.diabres.2008.11.030

10.2337/dc05-2425

10.2337/dc07-1302

Davis J, 1910, Skin transplantation with a review of 550 cases at the Johns Hopkins Hospital, John Hopkins Med J, 15, 307

Sabella N, 1913, Use of fetal membranes in skin grafting, Med Records NY, 83, 478

10.1001/jama.1913.04340130021008

ArnoldY LerouxJD WilliamsM DanilkovitchA. A comparison study of the anti‐oxidant effects of cellular versus acellular human repair matrices. In:Symposium on Advanced Wound Care; 2013 May 2–5; Las Vegas (NV).

ArnoldY LerouxJD WilliamsM DanilkovitchA. A comparison study of the angiogenic effect of cellular versus acellular human repair matrices. In:Symposium on Advanced Wound Care; 2013 May 2–5; Las Vegas (NV).

ArnoldY LerouxJD WilliamsM DanilkovitchA. A comparison study of the anti‐inflammatory effects of cellular versus acellular human repair matrices. In:Symposium on Advanced Wound Care; 2013 May 2–5; Las Vegas (NV).